{
    "version": "https:\/\/jsonfeed.org\/version\/1.1",
    "title": "Konstantin Chernyshov: posts tagged 2024",
    "_rss_description": "Konstantin Chernyshov, manager, bioinformatic, leader in biotech",
    "_rss_language": "en",
    "_itunes_email": "",
    "_itunes_categories_xml": "",
    "_itunes_image": "https:\/\/kostachernyshov.com\/blog\/pictures\/userpic\/userpic-square@2x.jpg?1731242071",
    "_itunes_explicit": "no",
    "home_page_url": "https:\/\/kostachernyshov.com\/blog\/tags\/2024\/",
    "feed_url": "https:\/\/kostachernyshov.com\/blog\/tags\/2024\/json\/",
    "icon": "https:\/\/kostachernyshov.com\/blog\/pictures\/userpic\/userpic@2x.jpg?1731242071",
    "authors": [
        {
            "name": "Konstantin Chernyshov",
            "url": "https:\/\/kostachernyshov.com\/blog\/",
            "avatar": "https:\/\/kostachernyshov.com\/blog\/pictures\/userpic\/userpic@2x.jpg?1731242071"
        }
    ],
    "items": [
        {
            "id": "34",
            "url": "https:\/\/kostachernyshov.com\/blog\/all\/publications-in-2024\/",
            "title": "Publications in 2024",
            "content_html": "<p>In 2024, I worked as the head of a group of bioinformaticians at BostonGene. Part of our department’s work involves scientific research on topical subjects that we either generate ourselves or receive as a client request. Participating in conferences allows us to present ourselves as experts in the field, make new acquaintances, and start projects.<\/p>\n<p>As a project lead, I proposed research topics, kept track of deadlines and workloads. Below are selected projects.<\/p>\n<h2>American Society of Clinical Oncology<\/h2>\n<p>The main clinical oncology conference in the USA.<\/p>\n<div class=\"e2-text-picture\">\n<div class=\"fotorama\" data-width=\"1605\" data-ratio=\"1.716577540107\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo.png\" width=\"1605\" height=\"935\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo-zoom1.png\" width=\"962\" height=\"841\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo-zoom2.png\" width=\"1066\" height=\"788\" alt=\"\" \/>\n<\/div>\n<div class=\"e2-text-caption\">“Transcriptomic Analysis Identifies Novel Tumor Suppressor Gene Fusions in Bone Sarcomas”.<br \/>\n<a href=\"https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.11523\">ASCO abstracts<\/a>.<\/div>\n<\/div>\n<h2>Society of Immunotherapy of Cancer<\/h2>\n<p>The largest conference on cancer immunotherapy; this year it took place in Barcelona.<\/p>\n<div class=\"e2-text-picture\">\n<div class=\"fotorama\" data-width=\"1595\" data-ratio=\"1.6842661034847\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc.png\" width=\"1595\" height=\"947\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc-zoom1.png\" width=\"1159\" height=\"787\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc-zoom2.png\" width=\"1025\" height=\"942\" alt=\"\" \/>\n<\/div>\n<div class=\"e2-text-caption\">“Identifying novel targets for antibody-drug conjugates in sarcomas using RNA sequencing”.<br \/>\n<a href=\"https:\/\/bostongene.com\/news-and-publications\/publications\/identifying-novel-targets-for-antibody-drug-conjugates-in-sarcomas-using-rna-sequencing?qr=1\">BostonGene news<\/a>.<br \/>\n<a href=\"https:\/\/doi.org\/10.1136\/jitc-2024-SITC2024.0170\">SITC abstracts<\/a>.<\/div>\n<\/div>\n<h2>Association of Molecular Pathology<\/h2>\n<p>A large conference in Canada attended by pathologists, pharma and biotech.<\/p>\n<div class=\"e2-text-picture\">\n<div class=\"fotorama\" data-width=\"1599\" data-ratio=\"1.7746947835738\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/CCS-full.png\" width=\"1599\" height=\"901\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/CCS-zoom1.png\" width=\"1579\" height=\"886\" alt=\"\" \/>\n<\/div>\n<div class=\"e2-text-caption\">“Comparative Molecular Analysis of Clear Cell Sarcoma and Cutaneous Melanomas: Key Genetic Insights for diagnosis”. <a href=\"https:\/\/bostongene.com\/news-and-publications\/publications\/comparative-molecular-analysis-of-clear-cell-sarcoma-and-cutaneous-melanomas-key-genetic-insights-for-diagnosis?qr=1\">BostonGene news<\/a>.<br \/>\n<a href=\"https:\/\/doi.org\/10.1016\/S1525-1578(24)00232-0\">APM abstracts<\/a>.<\/div>\n<\/div>\n<h2>American Society of Hematology<\/h2>\n<p>The largest conference on lymphomas and blood disorders in the world.<\/p>\n<div class=\"e2-text-picture\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/dlbcl-full.png\" width=\"1486\" height=\"954\" alt=\"\" \/>\n<div class=\"e2-text-caption\">“Gene Expression-Based Classifier Reclassifies Burkitt Lymphoma, HGBL NOS, DLBCL NOS, and Double\/Triple Hit Lymphomas into Subtypes with More Mutational and Microenvironment Landscapes and Treatment Response”. <a href=\"https:\/\/bostongene.com\/news-and-publications\/publications\/gene-expression-based-classifier-reclassifies-burkitt-lymphoma-hgbl-nos-dlbcl-nos-and-double-triple-hit-lymphomas-into-subtypes-with-more-uniform-mutational-and-microenvironment-landscapes-and-treatment-response?qr=1\">BostonGene news<\/a>.<br \/>\n<a href=\"https:\/\/ash.confex.com\/ash\/2024\/webprogram\/Paper200975.html\">ASH conference website<\/a>.<\/div>\n<\/div>\n<h2>San-Antonio Breast Cancer Symposium<\/h2>\n<p>The largest breast cancer conference in the world.<\/p>\n<div class=\"e2-text-picture\">\n<div class=\"fotorama\" data-width=\"1599\" data-ratio=\"1.7323943661972\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-ilc.png\" width=\"1599\" height=\"923\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-ilc-zoom1.png\" width=\"1097\" height=\"903\" alt=\"\" \/>\n<\/div>\n<div class=\"e2-text-caption\">“Comprehensive Analysis of ADC Target Expression in Invasive Lobular Carcinoma”.<br \/>\n<a href=\"https:\/\/bostongene.com\/news-and-publications\/publications\/comprehensive-analysis-of-adc-target-expression-in-invasive-lobular-carcinoma?qr=1\">BostonGene news<\/a>.<\/div>\n<\/div>\n<div class=\"e2-text-picture\">\n<div class=\"fotorama\" data-width=\"1593\" data-ratio=\"1.7428884026258\">\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-full.png\" width=\"1593\" height=\"914\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-zoom-1.png\" width=\"1544\" height=\"871\" alt=\"\" \/>\n<img src=\"https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-zoom-2.png\" width=\"920\" height=\"907\" alt=\"\" \/>\n<\/div>\n<div class=\"e2-text-caption\">“Evaluating the Correlation Between FISH and NGS in Assessing ERBB2 Amplification in Breast Cancer: Insights and Implications”. <a href=\"https:\/\/bostongene.com\/news-and-publications\/publications\/evaluating-the-correlation-between-fish-and-ngs-in-assessing-erbb2-amplification-in-breast-cancer-insights-and-implications?qr=1\">BostonGene news<\/a>.<\/div>\n<\/div>\n",
            "date_published": "2026-05-03T18:19:29+04:00",
            "date_modified": "2026-05-03T18:19:22+04:00",
            "tags": [
                "2024",
                "portfolio"
            ],
            "image": "https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo.png",
            "_date_published_rfc2822": "Sun, 03 May 2026 18:19:29 +0400",
            "_rss_guid_is_permalink": "false",
            "_rss_guid": "34",
            "_rss_enclosures": [],
            "_e2_data": {
                "is_favourite": false,
                "links_required": [
                    "jquery\/jquery.js",
                    "fotorama\/fotorama.css",
                    "fotorama\/fotorama.js"
                ],
                "og_images": [
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo-zoom1.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/fusions-in-osteo-zoom2.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc-zoom1.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-sarc-zoom2.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/CCS-full.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/CCS-zoom1.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/dlbcl-full.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-ilc.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/adc-in-ilc-zoom1.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-full.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-zoom-1.png",
                    "https:\/\/kostachernyshov.com\/blog\/pictures\/FISH-vs-NGS-zoom-2.png"
                ]
            }
        }
    ],
    "_e2_version": 4171,
    "_e2_ua_string": "Aegea 11.4 (v4171e)"
}